Starting Age for Cetirizine in Children
Cetirizine can be started at 6 months of age, with a dose of 0.25 mg/kg twice daily (approximately 2.5 mg twice daily for a typical infant). 1, 2
Age-Specific Dosing Guidelines
Infants 6-11 Months
- Approved starting age: 6 months in the United States 1, 3
- Dose: 0.25 mg/kg twice daily (approximately 2.5 mg twice daily for a 10 kg infant) 1, 2
- This dosing has been validated in prospective, randomized, double-blind, placebo-controlled studies specifically in this age group 2
Children 12-23 Months
- Continue 0.25 mg/kg twice daily 4
- Long-term safety (up to 18 months) has been established in children with atopic dermatitis starting at 12-24 months of age 4
Children 2-5 Years
Children 6 Years and Older
- Dose: 5-10 mg once daily 6, 7
- The 10 mg dose provides significantly better symptom control than 5 mg for seasonal allergic rhinitis 7
Critical Safety Considerations
Do NOT Use Below 6 Months
- Cetirizine is not recommended for infants under 6 months of age 8
- British guidelines specifically advise consulting product labeling and avoiding use below 6 months 8
- The one-month difference between 5 and 6 months is clinically significant due to lack of safety data 8
Safety Profile in Approved Age Groups
- In infants 6-11 months, cetirizine showed a safety profile similar to placebo with no increase in adverse events 2
- No cardiac effects (QTc prolongation) were observed in infants 2, 4
- Long-term use (18 months) showed no effects on growth, development, or behavior in children 12-24 months 4
Common Pitfalls to Avoid
Renal Impairment
- Cetirizine requires dose reduction in moderate renal impairment and should be avoided in severe renal impairment due to predominantly renal excretion 8
- Consider baseline renal assessment if prolonged use (>6 months) is planned 8
Avoid First-Generation Antihistamines
- Never use diphenhydramine or other first-generation antihistamines in children under 6 years for routine allergic symptoms 5
- Between 1969-2006, there were 69 deaths associated with antihistamines in children under 6 years, with diphenhydramine responsible for 33 of these deaths 5
Formulation Matters
- Use liquid formulations in young children for easier administration and better absorption 5
- Avoid OTC cough and cold combination products in children under 6 years due to overdose risk 5
Clinical Context for Use
Approved Indications
- Allergic rhinitis (seasonal and perennial) 9, 3
- Chronic idiopathic urticaria 9, 3
- Atopic dermatitis with allergic sensitization (reduces asthma risk in sensitized infants) 8, 9